Y-mAbs Therapeutics: Cash and Cash Equivalents Anticipated to Continue to Support Ops as Currently Planned Into 2027 >YMAB
Y-mAbs Therapeutics: Cash and Cash Equivalents Anticipated to Continue to Support Ops as Currently Planned Into 2027 >YMAB
y-mabs therapeutics：現金及現金等價物預計將繼續支持截至2027年當前計劃的運營壓力位>YMAB
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間